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Introduction
Voltage-gated potassium channels of the Kv1 subfamily play an 
important role in regulating the initiation and the shape of the 
axonal action potential, as well as synaptic efficiency (Bean, 
2007; Clark et al., 2009; Johnston et al., 2010). In addition, 
mutations in genes encoding Kv1 channel subunits have been 
implicated in the etiology of several neuronal excitability dis-
orders and diseases (Adelman et al., 1995; Kullmann and Hanna, 
2002; Jen et al., 2007). Importantly, Kv1 channel complexes 
show intricate axonal localizations with regard to their subunit 
composition and discrete subdomain distributions. For example, 
in neocortical layer 2/3 pyramidal neurons, in pyramidal neu-
rons in hippocampal CA1, and in retinal ganglion cells, Kv1.1 
and Kv1.2 subunits are highly clustered at the distal end of the 
axon initial segment (AIS) (Inda et al., 2006; Van Wart et al., 
2007; Goldberg et al., 2008; Lorincz and Nusser, 2008). In the 
case of myelinated nerve fibers, Kv1 channels are restricted be-
neath the myelin sheath and flanking each node of Ranvier at 
sites termed juxtaparanodes (Wang et al., 1993; Rhodes et al., 
1995; Rasband, 2004). However, the mechanisms underlying 
the precise assembly of high density populations of Kv1 chan-
nels in distinct axonal membrane subdomains remain elusive.
Kv1 channels function as supramolecular protein com-
plexes, composed of four pore-forming and voltage-sensing princi-
pal, or , subunits, with four cytoplasmic auxiliary Kv subunits 
(Rhodes et al., 1996; Pongs et al., 1999; Long et al., 2005). 
These Kv1 (Kv1.1–1.8) and Kv (Kv1, Kv2) subunits can 
heteromultimerize  to  yield  biophysically  and  pharmacologi-
cally distinct channel complexes (Ruppersberg et al., 1990; 
Rettig et al., 1994; Xu et al., 1998). Auxiliary Kv subunits are 
each 300 amino acids in length and contain a unique N-terminal 
domain followed by a common conserved core (over 85% amino 
acid identity; Trimmer, 1998). Studies of Kv1 channel bio-
synthesis have shown that Kv1 and Kv subunits coassemble in 
the ER and remain together as a stable complex (Shi et al., 1996; 
K
v1 channels are concentrated at specific sites in 
the axonal membrane, where they regulate neuro-
nal excitability. Establishing these distributions re-
quires regulated dissociation of Kv1 channels from the 
neuronal trafficking machinery and their subsequent in-
sertion into the axonal membrane. We find that the auxil-
iary Kv2 subunit of Kv1 channels purified from brain is 
phosphorylated on serine residues 9 and 31, and that   
cyclin-dependent kinase (Cdk)–mediated phosphorylation at 
these sites negatively regulates the interaction of Kv2 with 
the microtubule plus end–tracking protein EB1. Endog-
enous Cdks, EB1, and Kv2 phosphorylated at serine 31 
are colocalized in the axons of cultured hippocampal 
neurons, with enrichment at the axon initial segment (AIS). 
Acute inhibition of Cdk activity leads to intracellular accu-
mulation of EB1, Kv2, and Kv1 channel subunits within 
the AIS. These studies reveal a new regulatory mechanism 
for the targeting of Kv1 complexes to the axonal membrane 
through the reversible Cdk phosphorylation-dependent 
binding of Kv2 to EB1.
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complexes by SDS-PAGE. The Coomassie blue–stained band 
representing the putative Kv2 subunit pool of Mr ≈ 40 kD was 
excised and subjected to in-gel trypsin digestion. Peptides were 
fractionated and identified using LC-MS/MS. A Mascot data-
base search of identified mass spectra resulted in 437 matched 
peptides and 79% overall coverage of the Kv2 primary se-
quence  (Fig.  1).  From  these  analyses,  four  phosphorylated 
amino  acids  were  unambiguously  identified:  phosphoserines 
at S9 (TTGpSPAR), S20 (QTGpSPGM), S31 (TRYGpSPKR), 
and S112 (WRRSpSLVIT; Fig. 1 and Table I). Using this same 
approach, we also unambiguously identified the S20 and S112 
phosphosites  on  Kv2  copurified  with  Kv1.2  from  extracts 
of mouse brain, and pS31 and pS112 from extracts of human   
hippocampus (Table I). The pS9, pS20, and pS31 sites are pres-
ent on the unique N terminus of Kv2 (aa 1–38). In contrast, 
pS112 is present within the core domain that is highly conserved 
among all Kv subunits, and the tryptic peptide containing this 
site (GWRRSpSLVITTK) is 100% identical in Kv1. However, 
as no peptides unique to Kv1 were identified in these analyses, 
we assume the peptide containing pS112 originated from Kv2. 
These data show that Kv2 is phosphorylated in a similar but 
not identical pattern when purified from rat, human, and mouse 
brain. Note that recent high throughput mouse brain phospho-
proteomic studies have provided evidence for Kv2 phosphory-
lation at S9, S20, and S112 (Baek et al., 2011).
Nagaya and Papazian, 1997). Kv subunits primarily attach to 
the tetramerization or T1 domain present on the cytoplasmic   
N termini of Kv1 subunits (Sewing et al., 1996; Gulbis et al., 
2000; Long et al., 2005). Cryo-electron microscopy (Orlova   
et al., 2003; Sokolova et al., 2003) and x-ray crystallography 
(Gulbis et al., 1999, 2000; Long et al., 2005) studies of the 
Kv1/Kv channel complex place the Kv subunits as a large 
cytoplasmic mass hanging well beneath the cytoplasmic face of 
the pore module of Kv1 channels. Compelling data demonstrate 
that  cytoplasmic  Kv2  subunits,  which  do  not  dramatically   
affect the inactivation of Kv1 channels as do Kv1 subunits 
(Rettig et al., 1994), are the predominant Kv subunit in mam-
malian brain (Rhodes et al., 1996). Kv2 is involved in ER ex-
port of Kv1 channels (Shi et al., 1996; Nagaya and Papazian, 
1997; Campomanes et al., 2002) and controls Kv1 channel 
axonal targeting via its interaction with the microtubule plus 
end–tracking protein (+TIP) EB1 (Gu et al., 2003, 2006). The 
microtubule-based motor KIF3/ kinesin II and KIF5B are also 
implicated in Kv1 axonal targeting (Gu et al., 2006; Rivera   
et al., 2007). EB1 and its family members autonomously track 
microtubule tips, most likely by recognizing structural features 
of growing microtubule ends (Bieling et al., 2007; Vitre et al., 
2008; Dixit et al., 2009). The C-terminal moiety of EB1 is de-
scribed as an important domain for mediating EB1 binding to 
an array of structurally and functionally unrelated +TIP-binding 
partners, such as the adenomatous polyposis coli (APC) tumor 
suppressor  protein  and  CLIP-associated  proteins  (CLASPs; 
Honnappa et al., 2005, 2009). Phosphorylation of a number of 
these EB1-binding proteins negatively regulates their associa-
tion with EB1 (Honnappa et al., 2009; Kumar et al., 2009). As 
Kv2 is a stable, component subunit of Kv1 channel complexes 
(Shi et al., 1996; Nagaya and Papazian, 1997), the regulated 
dissociation of Kv2 from the channel complexes does not 
appear to be a viable mechanism for separating Kv1 channel 
complexes from EB1 and microtubules (MTs). This raised 
questions as to whether Kv2–EB1 interaction itself could be 
dynamically  regulated  through  phosphorylation,  and  conse-
quently modulate the targeting of Kv1 channels to specific sites 
in axons. Here we identified novel in vivo phosphorylation sites 
(phosphosites) on Kv2. Our functional analysis of the role of 
phosphorylation at these sites shows that Kv2–EB1 interac-
tion is negatively regulated by Cdk-mediated phosphorylation, 
and that Kv2 phosphorylation is critical in regulating the axo-
nal targeting of Kv1-containing Kv channels.
Results
Identification of in vivo phosphosites on 
brain Kv2
To identify in vivo Kv2 phosphosites, we undertook an un-
biased liquid chromatography tandem mass spectrometry (LC-
MS/MS)–based analysis of Kv2 subunits immunopurified from 
mammalian brain. To specifically isolate the population of brain 
Kv2 associated with Kv1 channels, we used an anti-Kv1.2 
antibody (Ab) to coimmunopurify Kv1/Kv2 complexes from 
detergent extracts of a crude rat brain membrane (RBM) frac-
tion. We then size-fractionated the components of the purified 
Figure 1.  In vivo phosphosites on mammalian brain Kv2. (A) Identi-
fication of phosphosites on rat brain Kv2 using LC-MS/MS. A doubly 
charged, singly phosphorylated peptide at m/z 647.8, derived from Kv2 
purified from rat brain, was fragmented to produce this MS/MS spectrum 
with a y- and b-ion series that described the sequence MYPESTTGpSPAR 
(aa 1–12). The phosphosite was unambiguously assigned to Ser9 because 
of mass assignments from -eliminated y4, y5, y8, y10, b9, and b11 fragment 
ions with neutral loss of phosphoric acid H3PO4. (B) Deduced amino acid 
sequence of rat Kv2. Phosphorylated serine residues, identified by MS, 
are in red. The sequence coverage is indicated in bold.815 Kv2 phosphorylation regulates Kv1 channel targeting • Vacher et al.
distribution when expressed in the absence of Kv2 (Fig. 2 D; 
API = 0.74 ± 0.17, n = 13), and a highly polarized axonal sur-
face distribution when coexpressed with Kv2 (Fig. 2 D; API = 
1.90 ± 0.35, n = 17; significantly [P < 0.05] different than with 
no Kv2). In contrast, when Kv1.2 was coexpressed with either 
the S9A or S31A mutant, it exhibited a nonpolarized surface 
distribution similar to that observed in the absence of Kv2 
(Fig. 2 D; API = 0.73 ± 0.21, n = 14; and API = 0.73 ± 0.23, n = 14, 
respectively,  not  significantly  different  than  with  no  Kv2). 
Moreover, the expression of S9A/S31A in mature neurons (e.g., 
endogenously expressing Kv1 channels and Kv2) also led to a 
decrease in the axonal distribution of endogenous Kv1.2 (Fig. S2). 
Together, these results indicate that Kv2 S9 and S31 are cru-
cial to both the intracellular trafficking of Kv1.2 to the cell sur-
face and the axonal localization of cell surface Kv1.2.
Although none of the identified phosphosites are located 
in the region of Kv2 that serves as the primary mediator of its 
interaction with Kv1.2 (Gulbis et al., 2000; Long et al., 2005), 
we nonetheless determined experimentally whether mutations 
at these sites could impact Kv1.2 trafficking by simply disrupt-
ing the interaction of Kv2 with Kv1.2. We performed reci-
procal coimmunoprecipitation experiments from coexpressing 
COS-1 cells, and found that both WT and mutant Kv2 sub-
units were associated with Kv1.2 (Fig. 2 E), and vice versa (not 
depicted). Anti-Kv2 Abs did not directly immunoprecipitate 
Kv1.2 (Fig. 2 E), and anti-Kv1.2 Abs did not immunoprecipi-
tate Kv2 (not depicted). These results suggest that the negative 
impact of the S9A and S31A mutations on the intracellular traf-
ficking and axonal localization of cell surface Kv1.2 are due to 
events subsequent to Kv1.2/Kv2 assembly.
Kv2 S9 and S31 are key residues in 
modulating the interaction of  
Kv2 with EB1
A previous study showed that axonal targeting of Kv1.2 is de-
pendent on the direct interaction of Kv2 with EB1, and that 
Kv2  associates  with  the  EB1  C  terminus  via  interactions   
requiring  intact  Kv2  N-terminal  (aa  1–90)  and  C-terminal   
(aa 338–367) domains (Gu et al., 2006). The model that arose 
from these studies is that association of Kv2 with EB1 enables 
the recruitment of Kv1–Kv2 complexes to MTs, allowing for 
the transport of these complexes to the axon (Gu et al., 2006).   
To determine whether the disruption of Kv2-mediated Kv1.2 
axonal compartmentalization by the S9A and S31A mutations 
was due to a perturbation of interaction with EB1, we first exam-
ined the recruitment of these Kv2 phosphosite mutants along 
Impact of S9 and S31 Kv2 mutations on 
Kv1 channel axonal targeting in neurons
Previous studies showed that Kv auxiliary subunits and Kv1 
subunits coassemble before the resultant 44 channel com-
plexes exit the ER (Shi et al., 1996; Nagaya and Papazian, 1997) 
and that Kv2 association is crucial for efficient cell surface 
trafficking of Kv1.2 (Shi et al., 1996; Campomanes et al., 2002). 
To determine if any of the identified Kv2 phosphosites are 
involved in cell surface trafficking of Kv1.2, we replaced the 
phosphorylated Ser residues with Ala residues. We first looked at 
the effect of these phosphosite mutations on the cell surface ex-
pression of Kv1.2 using immunostaining with an ectodomain- 
directed anti-Kv1.2 Ab (Kv1.2e). Coexpression of Kv1.2 with 
the S9A, S31A, and S9A/S31A mutants in COS-1 cells led to a 
decrease of the number of cells exhibiting cell surface immuno-
staining for Kv1.2, when compared with coexpression with 
wild-type (WT) Kv2, or with the S20A and S112A mutants 
(Fig. 2 A). We also observed a significant reduction in Kv1.2 
ionic  currents  in  whole-cell  patch-clamp  recordings  of 
HEK293 cells expressing either S31A (Fig. 2 B) or S9A (not 
depicted), when compared with cells expressing WT Kv2 
(Fig. 2 B) or S20A (not depicted). The macroscopic voltage- 
dependent activation and inactivation gating characteristics of 
Kv1.2 were not detectably different in cells coexpressing mu-
tant and WT Kv2. Together, these results indicate that phos-
phorylation at S9 and S31 is involved in regulating cell surface 
expression levels of Kv1.2, presumably due to effects on intra-
cellular trafficking.
In hippocampal neurons in culture, Kv2 mediates the 
polarized targeting of Kv1 channel complexes to axons (Gu   
et al., 2003). We next asked whether mutating Kv2 phospho-
sites would affect the polarized expression of Kv1.2 in axons. 
Rat hippocampal neurons in culture were cotransfected at   
7 days in vitro (DIV), a time before the expression of endog-
enous Kv1 subunits and Kv2 (Gu et al., 2006), with Kv1.2 
and WT or mutant isoforms of Kv2, and the localization of 
cell surface Kv1.2 determined 2–3 d later. Intact neurons were 
immunostained with the external Kv1.2e Ab to detect surface 
Kv1.2, and then permeabilized and immunostained to deter-
mine the localization of the overall population of WT and mu-
tant  cytoplasmic  Kv2  subunits  (Fig.  2  C). To  quantify  the 
polarity of the expression of cell surface Kv1.2, we determined 
the surface axonal polarity index (API), defined as the ratio of 
average  fluorescence  intensity  for  major  axonal  to  dendritic 
branches (Gu et al., 2003). As previously shown (Gu et al., 
2003), cell surface Kv1.2 exhibited a nonpolarized surface   
Table I. LC-MS/MS identification of in vivo phosphosites on Kv2 purified from brain
Phosphorylation site Native
Rat brain Mouse brain Human HC
pS9 +  
pS20 + + 
pS31 +  +
pS112 + + +
HC, hippocampus; +, identified phosphorylation site; , phosphorylation site not identified.JCB • VOLUME 192 • NUMBER 5 • 2011   816
Figure 2.  Mutating Kv2 N-terminal phosphosites impacts Kv1.2 cell surface expression. (A) Intact COS-1 cells cotransfected with rat Kv1.2 and WT 
Kv2, or Kv2 mutants (S9A, S20A, S31A, S112A, and S9A/S31A) were double immunostained with external Kv1.2e Ab, followed by permeabilization 
and immunostaining with K14/16 mAb. A surface expression efficiency index was determined as the percentage of Kv1.2-expressing (K14/16-positive) 
cells that exhibited Kv1.2e surface immunostaining (Kv1.2 + Kv2 = 49.2 ± 2.7%; Kv1.2 + S9A = 40.7 ± 1.2%; Kv1.2 + S31A = 37.8 ± 1.8%; and   
Kv1.2 + S9A/S31A = 28.7 ± 12.0%). Statistical significance was determined by one-way ANOVA followed by Tukey’s post hoc test and statistical 
significance was considered at: *, P < 0.05; and ***, P < 0.001 (n = 6 experiments of 100 Kv1.2-positive cells counted per experiment). (B) Whole-cell 
patch-clamp recordings from HEK293 cells expressing rat Kv1.2 alone (squares), or Kv1.2 together with WT Kv2 (circles), or the Kv2 S31A mutant 
(triangles). The cells were held at 80 mV and step depolarized to +40 mV for 200 ms in +10-mV increments. Peak current amplitudes at each test 
potential were divided by the cell capacitance to obtain the current densities. Mean ± SE of current densities obtained (Kv1.2, n = 14; Kv1.2 + Kv2, n = 5;   
Kv1.2 + S31A, n = 5) were plotted against each test potential. (C) Cultured hippocampal neurons (7 DIV) were cotransfected with Kv1.2 and either   
WT Kv2 or Kv2 S31A. 2 d after transfection, intact neurons were immunostained with Kv1.2e Ab, and then permeabilized and immunostained with   
anti-Kv2 and anti-MAP2 Abs. White arrows indicate the axon. Bar, 50 µm. (D) Surface axonal polarity index was determined by quantifying the surface 
immunofluorescence intensity profiles of the axon versus three dendritic branches using NIH Neuron/J. (E) Coimmunoprecipitation assays from heterol-
ogous cells coexpressing Kv2 mutants and Kv1.2 channels. Input into and products of immunoprecipitation reactions performed with anti-Kv2 mAb 
K25/73 on lysates from COS-1 cells coexpressing Kv1.2 and WT Kv2 or Kv2 mutants (S9A, S20A, or S31A), and immunoblotted for Kv1.2 using 
K14/16. Asterisk indicates the mouse IgG band. Input and IP lanes are not normalized.817 Kv2 phosphorylation regulates Kv1 channel targeting • Vacher et al.
enhances its binding to EB1 (Fig. 4 A), suggesting that phos-
phorylation of Kv2 also negatively regulates its binding to 
EB1. To determine which protein kinases could regulate Kv2–
EB1 interaction, we used consensus site algorithms to analyze 
the  sequences  surrounding  S9  and  S31  phosphosites.  These   
in silico analyses revealed a match for both S9 (pSPAR) and S31 
(pSPKR) phosphosites with the consensus motif [(S/T)PX(R/K)] 
for Cdk phosphorylation, specifically that catalyzed by Cdk2 
and Cdk5. To examine the possibility that Cdk-mediated phos-
phorylation regulated Kv2–EB1 interaction, we cotransfected 
Kv2 in COS-1 cells with active (Cdk2-HA) or dominant-
negative (D146N, Cdk2-DN) versions of Cdk2. GST-EB1C pull-
down assays were then performed on the extracts obtained from 
these cells. The presence of Cdk2-HA abrogated the binding of 
Kv2 to EB1, an effect that was not observed with Cdk2-DN 
(Fig. 4 B). We next used a phosphospecific Ab specific for Kv2 
phosphorylated at S31 (“Kv2P”; Fig. S1, B and C) to probe 
blots of bacterially expressed Kv2 that had been phosphory-
lated in vitro by either Cdk2/cyclin A or Cdk5/p35 purified 
complexes. Phosphospecific Kv2P immunoreactivity against 
Kv2 was detected in the reactions performed with either 
Cdk2/cyclin A or Cdk5/p35 (Fig. 4 C), showing that Kv2 could 
be directly phosphorylated by these Cdks. Together, these re-
sults show that Kv2–EB1 interaction is regulated by Cdk-
mediated phosphorylation of Kv2 at the S31 phosphosite, and 
perhaps by phosphorylation at other sites (e.g., S9) as well.
Cdk inhibition increases Kv2 recruitment 
to MTs and consequently decreases Kv1 
surface expression
To better understand the impact of Cdks on Kv2 properties, 
we first tested the impact of the pharmacological inhibition of 
Cdks on the recruitment of Kv2 to MTs. We treated COS-1 cells 
coexpressing Kv2 and EB1 for 24 h with roscovitine, an inhibitor 
of Cdk kinases (Cdk1, Cdk2, and Cdk5; Bach et al., 2005).   
MTs in the presence of EB1. As previously shown (Nakahira   
et al., 1998; Campomanes et al., 2002), we observed that Kv2 
expressed in COS-1 cells is present uniformly throughout the 
cytoplasm,  whereas  EB1-EGFP  is  mainly  found  along  MTs 
(Skube et al., 2010; unpublished data). However, coexpression 
of EB1-EGFP promoted the recruitment of Kv2 to MTs in 
57.0 ± 4.0% (n = 500 cells, three independent experiments) of 
cotransfected cells (Fig. 3). In contrast, the EB1-dependent MT 
recruitment of the S9A (40.2 ± 4.3%), S31A (41.6 ± 2.0%), and 
S9A/S31A (30.0 ± 3.0%) mutants was significantly decreased 
versus that observed for WT Kv2 (n = 500 cells, three inde-
pendent experiments; Fig. 3). To address whether these effects 
were due to differences in EB1 binding, we performed GST 
pull-down assays, similar to those used previously to demon-
strate Kv2–EB1 interaction (Gu et al., 2006), using bacterially 
expressed GST-EB1C (C-terminal domain, 165–268) and Kv2 
expressed in COS-1 cells. As shown in Fig. 3 C, the S9A and 
S31A mutants were deficient in EB1C binding relative to WT 
Kv2. These findings suggest that S9 and S31 are involved in 
regulating the association of Kv2 with EB1, and the EB1- 
mediated association of Kv2-containing channels with MTs.
Cdk phosphorylation negatively regulates 
the interaction between Kv2 and EB1
The interaction of EB1 with APC (Honnappa et al., 2005) and 
CLASP2 (Watanabe et al., 2009) is regulated through changes 
in phosphorylation state of these EB1 binding partners. As our 
mutagenesis results suggested that mutating Kv2 S9 and S31 
phosphosites altered Kv2 binding to EB1, we next determined 
whether Kv2 phosphorylation could modulate its interaction 
with EB1. We subjected cell extracts containing Kv2 (which is 
phosphorylated in heterologous cells; see Fig. S1) to digestion 
with alkaline phosphatase, and then subjected the extracts to 
pull-down assays with GST-EB1C (see previous paragraph). 
Our  results  show  that  dephosphorylation  of  Kv2  greatly   
Figure 3.  Mutating Kv2 N-terminal phosphosites impacts Kv2–EB1 interaction. (A) COS-1 cells cotransfected with EB1-EGFP and WT Kv2, or Kv2 
S31A (ratio 1:1). After methanol fixation, cells were immunostained with anti-Kv2 mAb K25/73 (red). Bar, 20 µm. (B) MT recruitment was quantified by 
dividing the number of cells with MT-like Kv2 immunostaining by the total number of cells coexpressing Kv2 and EB1; 500 cells were counted from three 
independent experiments. **, P < 0.01; ***, P < 0.001. (C) GST pull-down assays. Input and products of reactions performed with GST-EB1c on lysates 
from HEK293 cells expressing WT Kv2, or Kv2 mutants (S9A, S20A, or S31A) and immunoblotted with an anti-Kv2 mAb K25/73.JCB • VOLUME 192 • NUMBER 5 • 2011   818
The inhibition of Cdks dramatically increased the recruitment 
of Kv2 to MTs (Fig. 4 D). Importantly, inhibition of Cdks did 
not affect the MT recruitment of the S9A/S31A mutant, demon-
strating that the effects are mediated through Cdk phosphoryla-
tion of S9 and S31. We next looked at the effect of Cdk inhibition 
on the cell surface expression of Kv1.2. Roscovitine treatment 
of COS-1 cells coexpressing Kv1.2 and Kv2 led to a decrease 
of the number of cells exhibiting cell surface immunostaining 
for Kv1.2 (Fig. 4 E). Together, these results suggest that Cdk-
mediated phosphorylation of Kv2 releases Kv1–Kv2 com-
plexes from MTs, allowing for their expression in the plasma 
membrane, by disrupting Kv2 interaction with EB1.
Cdks and phosphorylated Kv2 colocalize 
with neuronal Kv1 complexes in vitro and 
in vivo
In brain, Kv1 channel complexes are found predominantly local-
ized to axons, where they show discrete cell type–dependent 
localization within subdomains of the axonal membrane (Wang 
et al., 1993; Rhodes et al., 1997; Lorincz and Nusser, 2008; 
Ogawa et al., 2008). Given the role of Cdks in mediating Kv2–
EB1 association revealed in the studies presented in the previ-
ous  paragraph,  we  first  examined  the  localization  of  Kv2 
phosphorylated at S31 using the phosphospecific Kv2P Ab to 
immunostain rat hippocampal neurons in culture. As the devel-
opmental expression of Kv1 complexes in cultured hippo-
campal neurons begins after 2 weeks of culture (Gu et al., 2006), 
we used hippocampal neurons at 3 weeks in culture (21 DIV) 
for these experiments. In these neurons, we observed Kv2P 
immunostaining in the axon, with a high concentration at the 
AIS (identified by ankyrin-G [Ank-G] immunostaining), and co-
localizing extensively with the overall pools of Kv2 (Fig. 4 A) 
and Kv1.2 (not depicted). Note that Kv2P also exhibited addi-
tional nuclear immunostaining that appeared to be nonspecific 
as it did not correspond to immunostaining for Kv2. Although 
Cdk2 immunostaining was broadly distributed throughout these 
cultured neurons, double immunostaining for Cdk2 and Kv2 
revealed these proteins colocalized in the axon, and specifically 
at  the AIS  (Fig.  5 A).  Similarly,  immunostaining  for  Cdk5, 
which was also broadly expressed in both somatodendritic and 
axonal  compartments,  exhibited  a  prominent  colocalization 
with Kv2 at the AIS (Fig. 5 A). To extend these results ob-
tained in cultured neurons, we next used immunostaining to ex-
amine the in vivo distribution of Cdks in myelinated axons, 
where Kv1 channels are highly enriched at the juxtaparanode 
(Rasband, 2004). The localization of Cdks in axons was as-
sessed on sciatic nerve sections, which have been used previ-
ously to define the juxtaparanodal localization of Kv1 subunits 
(Mi et al., 1995; Rasband et al., 1998) and Kv2 (Vabnick et al., 
1999). In adult mouse sciatic nerve, Cdk2 immunostaining co-
localized with that for Kv1.2 at the juxtaparanode, and was also 
present at the node of Ranvier (Fig. 5 B). Cdk5 immunostaining 
Figure 4.  Cdks regulate the interaction between Kv2 and EB1. (A) Effect 
of Kv2 phosphorylation on its interaction with EB1. Input and products 
of GST pull-down reactions performed with GST-EB1c on control and al-
kaline phosphatase–treated Kv2 lysates. GST was used as a negative 
control. The gel was blotted with anti-Kv2 mAb K25/73. (B) Role of Cdk2 
in regulating Kv2–EB1 interaction. Input and products of GST-EB1c pull-
down reactions performed on HEK293 lysates expressing Kv2 and either 
Cdk2-HA or Cdk2-DN, and blotted with an anti-Kv2 mAb K25/73. The 
control lane contains a GST-EB1c pull-down performed from HEK293 ly-
sates expressing Kv2 alone. (C) Immunoblots of bacterially expressed 
Kv2 phosphorylated in vitro in reactions containing no protein kinase ad-
dition (control), or purified human recombinant protein kinase complexes 
Cdk2/cyclin A, or Cdk5/p35, using the phosphospecific Ab Kv2P or 
anti-Kv2 mAb K25/73. (D) Effect of Cdk inhibition on the recruitment 
of Kv2 to MTs. COS-1 cells were cotransfected with EB1-EGFP and WT 
Kv2, or Kv2 S9A/S31A (ratio 1:1). After the transfection (i.e., subse-
quent to Kv1.2/Kv2 expression and assembly), cells were treated with 
20 µM roscovitine for 24 h. MT recruitment was quantified by dividing 
the number of cells with MT-like Kv2 immunostaining by the total number 
of cells coexpressing Kv2 and EB1; 500 cells were counted from three 
independent experiments. ***, P < 0.001. (E) Effect of Cdk inhibition on 
Kv1.2 surface expression. COS-1 cells were cotransfected with WT Kv1.2 
and Kv2 (ratio 1:4). After the transfection, cells were treated with 20 µM 
of roscovitine for 24 h. Intact COS-1 cells were double immunostained 
with external Kv1.2e Ab, and then after permeabilization with cytoplasmic 
anti-Kv1.2 K14/16 and anti-Kv2 K25/73 mAbs. A surface expression 
efficiency index was determined as the percentage of Kv1.2-expressing 
(K14/16-positive) cells with Kv1.2e surface immunostaining. Statistical sig-
nificance was considered at **, P < 0.01. (n = 3 independent experiments 
of 100 Kv1.2-positive cells counted per experiment).
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neurons at 20 DIV for 24 h with roscovitine. Because Kv1 
subunits, Kv2, Cdk2, Cdk5, and EB1 (Fig. S3) are all concen-
trated at the AIS, we analyzed the effects of Cdk inhibition on 
their AIS localization. Immunofluorescence staining intensity 
was quantified by taking the ratio of average fluorescence inten-
sity for the AIS, as defined by immunostaining for Ank-G, rela-
tive  to  that  on  dendrites.  In  roscovitine-treated  neurons,  the 
immunostaining for Kv2, EB1, Kv1.1, and Kv1.2 at the AIS 
was increased by an average of 30% compared with control 
(untreated) neurons (n = 50, three independent experiments; 
Fig. 6, A and B). The increase in Kv2 and Kv1.2 immuno-
staining after roscovitine treatment was also observed in proxi-
mal (adjacent to the AIS) and distal axonal domains (Fig. S4). 
However, the level of PSD-93, a scaffolding protein critical to 
anchoring of Kv1 channels at the AIS (Ogawa et al., 2008), was 
was also found enriched at the juxtaparanode in sciatic nerve 
axons, where it colocalized with Kv1.2 immunostaining, and 
was also found at the node of Ranvier and at the paranode 
(Fig. 5 B). Together, these observations demonstrate that axonal 
Cdk2 and Cdk5 localize at sites of high densities of Kv1–Kv2 
complexes in dissociated hippocampal neurons and in sciatic 
nerves, and show that these Cdks are at locations where they 
can  impact  phosphorylation-dependent  targeting  of  channel 
complexes into the axonal membrane.
Cdk inhibitors modulate the endogenous 
localization of Kv2, EB1, and Kv1 channels
Finally, we tested the impact of pharmacological inhibition of 
Cdks on the axonal localization of endogenous neuronal EB1, 
Kv2, and Kv1 subunits. We treated cultured hippocampal 
Figure 5.  Localization of endogenous Cdks, Kv2, and Kv1.2 in dissociated hippocampal neurons and in sciatic nerve. (A) Endogenous neuronal Kv2 
phosphorylated at S31, Cdk2, and Cdk5 are distributed along the axon with enrichment at the AIS. Cultured hippocampal neurons (21 DIV for Kv2P 
and Cdk2; 16 DIV for Cdk5) immunostained with phosphospecific Ab Kv2P, anti-Kv2 mAb K25/73, and either anti-Cdk2 or anti-Cdk5 Abs. MAP2 
immunostaining reveals the somatodendritic compartment and Ank-G immunostaining marks the AIS (arrows). Bars: 8 µm (top), 20 µm (middle), 10 µm 
(bottom). (B) Immunohistochemistry of adult mouse sciatic nerve. Immunostaining for Cdk2 is distributed at the node of Ranvier and at the juxtaparanode 
where it colocalizes with Kv1.2. Cdk5 immunostaining is enriched at the juxtaparanode, and is present at paranode and at the node of Ranvier. CASPR 
immunostaining marks the paranodal compartment. Bar, 10 µm.JCB • VOLUME 192 • NUMBER 5 • 2011   820
accumulation at these sites remain elusive, but presumably 
involve reversible protein–protein interactions between compo-
nent subunits of the Kv1 channel complex and constituents of 
the neuronal trafficking machinery. In this study, we reveal a 
novel mechanism regulating axonal targeting of Kv1 channels 
via the Cdk-mediated phosphorylation of the Kv2 auxiliary 
subunit. Our data suggest a model whereby phosphorylation of 
Kv2 disrupts its binding to EB1, which consequently releases 
the Kv1–Kv2-containing vesicles from their association with 
EB1 and axonal MTs. We first identified in vivo phosphosites 
on  Kv2  purified  from  mammalian  brain  using  a  phospho-
proteomic approach. We demonstrated that mutation of two of 
the identified phosphosites, at S9 and S31, impacts Kv2–EB1 
interaction,  and  that  Cdk-mediated  Kv2  phosphorylation 
negatively regulates this interaction. Furthermore, we showed 
that Cdk2 and Cdk5 directly phosphorylate Kv2 in vitro, and 
that inhibition of Cdks in heterologous cells leads to an increase 
of Kv2 recruitment on MTs and a decrease of Kv1 surface ex-
pression. We found that endogenous Cdk2, Cdk5, phosphory-
lated Kv2, and EB1 in cultured hippocampal neurons are all 
present in axons, and that all are enriched at the AIS. Cdk2 and 
Cdk5 also colocalize with Kv1 channels at the juxtaparanode of 
sciatic nerves in vivo. Finally, acute inhibition of Cdks in cul-
tured hippocampal neurons leads to an increase in the levels of 
intracellular populations of axonal Kv2, EB1, and Kv1 chan-
nels without affecting the levels of either the surface population 
of Kv1 channels or the Kv1 channel anchoring protein PSD-93. 
not affected by roscovitine treatments. To extend these findings, 
we quantified levels of endogenous cell surface Kv1.1 subunits 
at the AIS in untreated and roscovitine-treated neurons, using   
an ectodomain-directed anti-Kv1.1 Ab. Our results showed that 
the levels of Kv1.1 present at the surface of the AIS remained 
the same after 24 h of Cdk inhibition (Fig. 6 C). Together, these 
findings reveal that in neurons the inhibition of Cdks also in-
creases the concentration of EB1 at the AIS, as well as the intra-
cellular populations of Kv1–Kv2 channel complexes, implying 
an accumulation of these proteins on axonal MTs. Together 
with our previous results in COS-1 cells (see Fig. 4, D and E), 
this strongly suggests that Cdks modulate the balance between 
the pool of intracellular Kv1–Kv2 complexes associated with 
MTs  via  a  phosphorylation-sensitive  Kv2–EB1  interaction, 
and the pool of plasma membrane Kv1–Kv2 complexes asso-
ciated with PSD-93.
Discussion
It has become clear that Kv1 channels present at the axon, espe-
cially at the AIS (Clark et al., 2009) and the juxtaparanode 
(Rasband, 2004), play a crucial role in controlling spike thresh-
old, shape, and repetitive firing (Johnston et al., 2010). As such, 
these channels have become an attractive target for therapeu-
tics aimed at restoring function in patients with peripheral 
demyelinating disorders (Judge et al., 2006). However, the mo-
lecular mechanisms responsible for their precise, high density 
Figure 6.  Effect of Cdk inhibition on the AIS 
localization  of  Kv2,  EB1,  Kv1  subunits,   
PSD-93, and Ank-G. (A) Cultured hippocampal 
neurons (21 DIV), with or without 10 µM rosco-
vitine treatment for 24 h, were multiple immuno-
fluorescence stained for Kv2, EB1, Kv1.2, 
and  PSD-93  as  noted,  together  with  Ank-G 
as a specific marker of the AIS. Bar, 20 µm.   
(B)  The  changes  in  AIS  accumulation  were 
quantified by the ratio of average fluorescent 
intensity for the AIS to dendritic branches using   
NIH Neuron/J and subjected to statistical analy-
sis using PRISM 5 (n = 60). ***, P < 0.001. 
(C)  Intact  neurons  were  immunostained  with 
Kv1.1e  mAb  K36/15,  and  then  permeabi-
lized and immunostained with anti-Kv1.1 and 
anti-Ank-G Abs. Surface axonal polarity index 
was  determined  by  quantifying  the  surface 
immunofluorescence  intensity  profiles  of  the 
AIS versus three dendritic branches using NIH 
Neuron/J and subjected to statistical analysis 
using PRISM 5 (n = 25). **, P < 0.01.821 Kv2 phosphorylation regulates Kv1 channel targeting • Vacher et al.
In neurons, Kv2 orchestrates forward trafficking (Shi   
et al., 1996; Campomanes et al., 2002; Gu et al., 2003) and sub-
sequent  axonal  targeting  (Gu  et  al.,  2003)  of  Kv1  channels 
through interactions with EB1 and the microtubule-based mo-
tors KIF3A (Gu et al., 2006). KIF5B has also been shown to be 
required for efficient targeting of Kv1 channels to axons (Rivera 
et al., 2007), but any potential Kv2–KIF5B interaction has not 
yet been characterized. One model derived from these studies is 
that Kv2 acts as an adaptor protein, linking Kv1-containing 
vesicles to these motor proteins. As such, Kv2 interaction with 
KIF3 (and possibly KIF5B), which likely occurs after Kv1- 
containing vesicles exit the Golgi apparatus, allows these vesi-
cles to be transported to the axon along MTs. Once KIF-driven 
vesicles containing Kv1–Kv2 complexes reach the plus end of 
MTs that are distributed distally along the axon, the Kv2 adap-
tor, and the associated Kv1-containing vesicles, can switch from 
binding these motors to binding EB1. The newly established 
Kv2–EB1 binding then allows the vesicles to either stay bound 
to the MTs, by shifting between different MTs in the bundle, or 
to be released to be locally inserted into the plasma membrane. 
Here, we found that Cdk phosphorylation inhibits Kv2 inter-
action with EB1, and that pharmacological inhibition of Cdks 
increases the recruitment of Kv2 to MTs in heterologous cells, 
and the concentration of Kv1–Kv2 complexes associated with 
EB1 in axons. Thus, it is tempting to propose that Cdks play a 
key role in promoting the release of Kv1–Kv2-containing ves-
icles from EB1. Such a scenario is consistent with previous 
studies showing that the unloading and transport efficiencies of 
other cargos are regulated by phosphorylation events (Sato- 
Yoshitake et al., 1992; Morfini et al., 2002; Guillaud et al., 
2008). Therefore, the phosphorylation of Kv2 by Cdks would 
act as a molecular switch that controls the release of Kv1- 
containing vesicles. We showed that Cdk inhibition decreases 
the Kv1 channel surface pool in heterologous cells and has no 
significant effect on the Kv1 surface pool and its anchoring pro-
tein PSD-93 in neurons. However, the inhibition of Cdks in het-
erologous cells was done at the outset of Kv1–Kv2 expression, 
in contrast to the experiments in neurons, where these channel 
complexes were already transported to and concentrated at the 
plasma membrane. Moreover, previous studies showed that the 
axonal  Kv1  complexes  anchored  by  PSD-93  at  the  plasma 
membrane are highly stable (Ogawa et al., 2008), and that PSD-93 
interacts with Kv1 complexes only when they are at the cell 
surface. Thus, it is likely that 24 h of Cdk inhibition is not long 
enough to induce a decrease of the concentration of either sur-
face Kv1 channels or PSD-93 at the AIS.
The reversible posttranslational modification of neuronal 
protein binding partners is a key process allowing a specific and 
dynamic network of interactions in response to neuronal activ-
ity. This process relies on the expression and activity of specific 
sets of protein kinases and phosphatases in distinct subcellular 
compartments. Here, we show that neuronal Cdks, which colocal-
ize in axons with Kv1 subunits, Kv2, and EB1, are impli-
cated in regulating Kv1 channel axonal compartmentalization. 
Thus, it is likely that the localization of Cdks at/near sites of 
high densities of axonal Kv1 channels spatially restricts where 
the phosphorylation events that regulate Kv2–EB1 occur. 
Together, our findings reveal a new regulatory mechanism for 
the targeting of Kv1 complexes to the axonal membrane through 
the reversible phosphorylation-dependent binding of Kv2 auxil-
iary subunits to EB1.
Here, we show that two Ser residues, S9 and S31, regulate 
the interaction of Kv2 with EB1, in that phosphorylation or 
mutation of either Ser residue disrupts Kv2–EB1 interaction. 
The S9 and S31 sites (SPAR and SPKR) are quite similar to a 
phosphosite (SPRK) that acts as a negative regulator of APC 
binding to EB1 (Honnappa et al., 2005, 2009). These Kv2 
phosphosites are located within the Kv2 N-terminal domain 
that among Kv subunits is unique to Kv2, suggesting that, 
among Kv family members, the reversible binding to EB1 
may be specific to the highly expressed Kv2. Honnappa et al. 
(2009) also identified a highly conserved “microtubule tip local-
ization signal” among EB1-binding partners, in the form of a 
short peptide motif Ser-X-Ile-Pro (SXIP) that targets these part-
ners to growing MT ends in an EB1-dependent manner. Phos-
phorylation of +TIPs at regulatory sites distinct from but near 
the SXIP EB1 binding motif negatively regulates the localiza-
tion of +TIPs to MT ends by decreasing their affinity for 
binding to EB1 (Honnappa et al., 2005, 2009). However, phos-
phorylation within the SXIP motif itself has not been detected 
(Honnappa et al., 2009). There exists a consensus SXIP motif 
within Kv2 (SGIP, aa 257–260), within a segment that among 
Kv subunits is also unique to Kv2, and that within the Kv2 
crystal structure forms a surface loop between the 1 strand and 
the G helix (Gulbis et al., 1999, 2000). However, we found that 
mutating either S257 or the entire SGIP motif to Ala did not 
abrogate Kv2–EB1 interaction (Fig. S5). This suggests that 
Kv2 possesses a mechanism for phosphorylation-dependent 
interaction with EB1 that is similar to but distinct from other 
EB1-binding proteins.
Moreover, although our results show a role for N-terminal 
Kv2  phosphorylation  acting  as  a  negative  regulator  of   
binding to EB1, they are distinct from those obtained for 
phosphorylation-dependent  regulation  of  EB1  binding  by 
CLASPs (Kumar et al., 2009; Watanabe et al., 2009). For example, 
Ser to Ala mutations in CLASPs yield constitutive CLASP/EB1 
binding that is refractory to phosphorylation-dependent regu-
lation. Similar mutations in Kv2 disrupt its binding to EB1, 
as do Ser to Asp mutations at these sites. We note that there 
are numerous cases where Ser to Ala mutations are disruptive 
to other protein–protein interactions that are negatively regu-
lated by phosphorylation. For example, while phosphoryla-
tion of GluR2 glutamate receptor subunit at S880 negatively 
regulates GluR2 binding to its partner GRIP (Matsuda  et  al., 
1999), mutation of S880 to either Ala (Osten et al., 2000) or 
Glu (Chung et al., 2000) disrupts this interaction, suggesting 
a similar requirement for an intact, unphosphorylated Ser for 
binding.  Similarly,  Kir2.3  channel  binding  to  the  PSD-95 
scaffolding protein is negatively regulated by phosphorylation 
at Kir2.3 S440, and by mutation of this Ser to Ala, Asp, or Glu 
(Cohen et al., 1996). The negative effects of phosphorylation, 
and of S9 and S31 mutations on Kv2 binding to EB1, may 
reflect a similar strict requirement for an unphosphorylated 
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Immunoprecipitations, immunoblotting, GST pull-downs, and  
alkaline phosphatase
Procedures  for  immunoprecipitation  and  immunoblot  analysis  were  per-
formed as reported previously (Park et al., 2006). Mouse anti-Kv2 mAb 
K25/73, generated against a C-terminal peptide corresponding to Kv2 
amino acids 350–367 (Rhodes et al., 1995), was used for immunoblots. For 
GST pull-downs, transfected cell extracts or purified bacterially expressed 
WT and mutant Kv2 isoforms were incubated 4 h to overnight at 4°C with 
GST-EB1C, GST-EB1, or GST prebound to glutathione–Sepharose 4B (GE 
Healthcare). The beads were then washed five times with lysis buffer (Vacher 
et al., 2007) and eluted with reducing sample buffer (125 mM Tris-HCl, 4% 
SDS, 20%, glycerol, and 2% -mercaptoethanol). Membrane preparations 
and cell lysates were incubated without or with 100 U/ml of alkaline phos-
phatase (Roche) as reported previously (Murakoshi et al., 1997).
In vitro phosphorylation assay
Bacterially expressed GST-Kv2 (Bekele-Arcuri et al., 1996) fusion protein 
(2.5 µg) was incubated with 100 ng of human recombinant Cdk com-
plexes (Invitrogen), either Cdk2/cyclin A, or Cdk5/p35, and 2 mM ATP in 
kinase reaction buffer (20 mM Tris-HCl, pH 7.5, 1 mM MgCl2, and 1 mM 
DTT) in a final volume of 50 µl for 15 min at 30°C. The reaction was 
stopped by adding 50 µl of 2x reducing sample buffer.
Plasmids and generation of mutant Kv2 cDNAs
Plasmids for transfection were as follows: rat Kv1.2/RBG4, rat Kv2/
RBG4  (Nakahira  et  al.,  1996),  EB1-EGFP  (a  gift  from  Michelle  Piehl,   
Lehigh  University,  Bethlehem,  PA),  Cdk2-HA  (Addgene  plasmid  1884), 
and Cdk2-DN (D146N, Addgene plasmid 1882; van den Heuvel and 
Harlow, 1993). Mutagenesis of recombinant rat Kv2 cDNA in the pRBG4 
or pGEX-6P vectors (Nakahira et al., 1996) was performed using the   
QuikChange site-directed mutagenesis kit (Agilent Technologies).
Generation of the phosphospecific Ab Kv2P
A synthetic peptide phosphorylated at S31 (aa 26–37, STRYG[pS]PKRQLQ) 
and the nonphosphorylated equivalent peptide were synthesized (Pi Pro-
teomics). The phosphopeptide was conjugated to keyhole limpet hemocyanin 
(EMD) at a ratio of 1 mg of peptide/mg of carrier protein using sulfo-m- 
maleimidobenzoyl-NHS ester (Thermo Fisher Scientific), and injected into 
rabbits for the production of polyclonal antisera (PRF&L). For affinity purifi-
cation, the phosphorylated and nonphosphorylated peptides were conju-
gated  to  SulfoLink  coupling  gel  (Thermo  Fisher  Scientific)  via  synthetic 
N-terminal cysteine residues, and phosphospecific Abs were affinity puri-
fied by a two-step affinity purification procedure (Park et al., 2006). Phos-
phospecificity was verified by ELISA assay against phosphorylated and 
nonphosphorylated peptide coupled to BSA.
Animals
Wistar rats (for neuronal cultures) and Swiss mice (for sciatic nerve immuno-
histochemistry) used follow the guidelines established by the European 
Animal Care and Use Committee (86/609/CEE). Mice were deeply anes-
thetized with pentobarbital (120 mg/kg b.w., i.p.).
Neuron culture, transfection, and inhibition of Cdk activity
Primary hippocampal neurons were prepared from hippocampi of E18 rats, 
as described previously (Goslin and Banker, 1989). In brief, dissociated 
neurons were plated onto poly-l-lysine–treated glass coverslips at a density 
of 2,500–7,500 cells/cm
2 and co-cultured over a monolayer of astrocytes. 
Cells were maintained in Neurobasal medium (Invitrogen) supplemented 
with B27 and glutamine. Neurons were transfected at 7 DIV or at 10 DIV 
using Lipofectamine 2000 (Invitrogen). The conditioned medium was sup-
plemented with 10 µM D-2-amino-5-phosphonopentanoic acid (Tocris Bio-
science). Transfected cells were processed for immunofluorescence 2 d after 
transfection.  Inhibition  of  Cdk  activity  was  performed  using  roscovitine 
(EMD), a potent inhibitor of Cdk1, Cdk2, and Cdk5 (Meijer et al., 1997; 
Bach et al., 2005). Roscovitine was dissolved in DMSO and added to the 
culture  medium  of  rat  hippocampal  neurons  at  a  final  concentration  of   
10 µM for 24 h. Controls included the same amount of DMSO alone.
Immunofluorescence staining
For surface immunofluorescence staining (Tiffany et al., 2000), cells were 
immunostained  48  h  after  transfection  with  ectodomain-directed  rabbit 
polyclonal Kv1.2e Ab (Shi et al., 1996) or, for immunostaining of endoge-
nous neuronal Kv1.1, at 21 DIV with ectodomain-directed mouse Kv1.1e 
mAb (K36/15; UC Davis/NIH NeuroMab Facility) before detergent per-
meabilization to detect the cell surface pool. The total cellular pools of the 
respective proteins were detected by immunostaining with cytoplasmically 
This ensures that Kv1 channels are localized at the correct sub-
cellular locations, and prevents their ectopic expression at sites 
that could result in deranged neuronal excitability. This is simi-
lar to the role proposed for the CK2 protein kinase, which is 
also highly enriched at the AIS and at nodes of Ranvier, and 
which regulates the local interaction between Nav channels and 
the scaffolding protein Ank-G (Bréchet et al., 2008). In this 
case, CK2-mediated phosphorylation increases the affinity of 
the Nav1 AIS-targeting motif for binding to Ank-G, ensuring 
that Nav channels are spatially restricted to sites (e.g., the AIS 
and nodes of Ranvier) that are enriched in Ank-G. The initiation 
of action potentials depends on the precise density of Nav and 
Kv channels at the AIS (Clark et al., 2009). Fine tuning of the 
expression levels and localization of these axonal ion channels, 
through  feedback  mechanisms  involving  signaling  pathways 
using the CK2 and Cdk protein kinases, and competing protein 
phosphatases, provides a powerful mechanism to dynamically 
regulate the biophysical properties of the spike-generating ma-
chinery and neuronal excitability.
Materials and methods
Preparation of brain membrane fractions and cell lysates
A crude synaptosomal membrane fraction was prepared from freshly dis-
sected adult rat or mouse brain, or from human hippocampal tissue from 
anonymous donors (the Brain and Tissue Bank for Developmental Disorders 
at the University of Maryland, Baltimore, MD) by homogenization in   
0.3 M sucrose, 5 mM sodium phosphate, pH 7.4, 5 mM NaF, 1 mM EDTA, 
anti-protease tablet (Roche), and centrifugations as described previously 
(Trimmer, 1991). The pellet of the crude membranes was suspended in the 
homogenization  buffer  and  protein  was  determined  using  the  BCA 
(bicinchoninic acid protein assay) method (Thermo Fisher Scientific). 
Harvested HEK293 and COS-1 cells or crude synaptosomal membrane 
were lysed in 1% Triton X-100 extraction buffer as described previously 
(Vacher et al., 2007). Cells were transiently transfected using the Lipo-
fectamine 2000 (Invitrogen) or Polyfect (QIAGEN) reagents using the 
manufacturer’s protocols.
Immunopurification, in-gel digestion, and MS
For large-scale immunopurification, 1% Triton X-100 extracts of rat brain 
membranes (RBM; 25 mg), mouse brain membranes (MBM; 10 mg), or   
human hippocampal membranes (10 mg) were incubated with affinity- 
purified rabbit anti-Kv1.2C polyclonal Ab (Rhodes et al., 1995), followed 
by binding to protein A–agarose beads. In-gel digestion of the Kv2 band 
excised from a Coomassie blue–stained SDS gel was performed in 10 ng/ml 
trypsin as described previously (Park et al., 2006). An ultra-performance 
liquid chromatography system (nanoACQUITY; Waters) directly coupled 
with an ion trap mass spectrometer (LTQ-FT; Finnigan) was used for LC-
MS/MS data acquisition. MS/MS spectra were interpreted through the 
Mascot searches (Matrix Science) with a mass tolerance of 20 ppm, MS/MS 
tolerance of 0.4 or 0.6 D, and one missing cleavage site allowed. Carb-
amidomethylation of cysteine, oxidation of methionine, and phosphoryla-
tion on serine, threonine, and tyrosine residues was allowed. Each filtered 
MS/MS  spectrum  exhibiting  possible  phosphorylation  was  manually 
checked and validated. Existence of a 98-D mass loss (H3PO4: phospho-
peptide-specific CID neutral loss) and any ambiguity of phosphosites were 
carefully examined (Park et al., 2006). All LC-MS/MS procedures were 
performed at the UC Davis Proteomics Facility.
Recombinant protein expression and purification
Plasmids  encoding  GST-EB1c  or  GST-EB1  were  a  gift  from  Gregg  G. 
Gunderson (Columbia University, New York, NY). All GST constructs were 
transformed into BL21 (DE3) Escherichia coli. Transformed bacteria cells 
were grown and GST proteins purified by chromatography on glutathione–
Sepharose 4B according to the manufacturer’s instructions (GE Health-
care). Cleavage of GST fusion protein (for GST-Kv2 or GST-Kv2 mutants) 
was performed using PreScission protease following the manufacturer’s   
instructions (GE Healthcare). Protein concentrations were determined by the 
BCA method (Thermo Fisher Scientific).823 Kv2 phosphorylation regulates Kv1 channel targeting • Vacher et al.
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chemistry, sciatic nerves were removed, fixed in 4% paraformaldehyde for 
10 min, and then cryoprotected using sucrose gradient before being frozen. 
Several cryostat sections of 12-µm and 25-µm thickness were made. The 
sections were blocked with 50 µg/ml BSA, 0.5% Triton X-100, 1% normal 
goat serum, and 1% normal donkey serum in PBS for 90 min. They were 
incubated overnight at 4°C with primary Abs in 10 µg/ml BSA, 0.1% normal 
goat serum, and 0.1% normal donkey serum in PBS, then with secondary 
Abs in the same buffer for 1 h. In some preparations, 0.1 µM DAPI nucleic acid 
stain (Invitrogen) was added for 10 min before mounting with FluorSave.
Electrophysiology
Outward  potassium  currents  were  recorded  at  room  temperature  from 
HEK293 cells transiently coexpressing recombinant Kv1.2 with WT or mu-
tant  Kv2  using  whole-cell  voltage-clamp  configuration.  Patch  pipettes 
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Online supplemental material
Fig. S1 shows the phosphorylation of Kv2 in heterologous cells and in 
mammalian brain. Fig. S2 shows the effect of Kv2 S9A/S31A mutant on 
endogenous Kv1.2 axonal distribution. Fig. S3 shows the subcellular distri-
bution of EB1 in cultured hippocampal neurons at 21 DIV. Fig. S4 shows the 
effect of Cdk inhibition on Kv1 channel and Kv2 distribution in proximal 
and distal axons. Fig. S5 shows the effect of the mutagenesis of Kv2 SGIP 
motif on its interaction with EB1. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201007113/DC1.
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